Fecal Transplant Noninferior to Vancomycin for Initial C. Diff Therapy

(MedPage Today) -- Fecal microbiota transplant might be considered for first-line treatment of Clostridioides difficile (C. diff), based on noninferiority findings from a randomized, open-label trial.
A similar proportion of patients receiving...